Related Experiment Video
Updated: May 8, 2026
04:25
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
[A novel typing method and scheme for Streptococcus pneumoniae]
Zuzana Vacková1, Martina Klímová, Jana Kozáková
1Statni zdravotni ustav, Praha. zuzana.vackova@szu.cz
Summary
A new multiplex polymerase chain reaction (mPCR) method enhances Streptococcus pneumoniae typing accuracy. This molecular technique offers a more precise alternative to traditional serological methods for identifying pneumococcal strains.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Streptococcus pneumoniae identification and typing traditionally rely on phenotypic methods like the Quellung reaction.
- These methods can be labor-intensive and may lack the precision required for accurate strain differentiation.
Purpose of the Study:
- To introduce and evaluate a novel multiplex polymerase chain reaction (mPCR) assay for Streptococcus pneumoniae typing.
- To assess the efficacy of the mPCR assay in the National Reference Laboratory (NRL) for Streptococcal Infections.
Main Methods:
- A novel multiplex polymerase chain reaction (mPCR) assay was developed and implemented.
- The mPCR assay was tested on 210 Streptococcus pneumoniae isolates and 8 isolates of related species (S. pseudopneumoniae, S. sanguinis, S. oralis).
Main Results:
- The mPCR assay successfully identified and typed all pneumococcal strains in the study.
- Related species isolates tested negative with the mPCR assay, demonstrating specificity.
- The mPCR assay exhibited 100% sensitivity and specificity for S. pneumoniae typing.
Conclusions:
- The National Reference Laboratory for Streptococcal Infections has adopted the novel mPCR assay for S. pneumoniae identification and typing.
- This molecular method provides a more accurate and efficient approach to pneumococcal typing compared to serological methods.
Related Concept Videos
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:13Special Staining Techniques
Specialized staining techniques play a vital role in microbiology by enabling the visualization of specific bacterial structures that remain undetectable with standard microscopy methods. These techniques not only enhance the structural visualization of bacterial cells but also provide critical insights into their pathogenicity and classification. Additionally, they support diagnostic and research endeavors in microbiology by identifying key bacterial features.Capsule Staining for Virulence...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: